TGTPG GP A, LLC
Institutional investor · Portfolio as of Q4 2021
Top Holdings43 positions
LIFESTANCE HEALTH GROUP INC | 175.3M | $1.7B | 16.7% | $9.52 | 0.00% | 1 qtr | First report 0 |
MCAFEE CORP | 59.9M | $1.5B | 15.4% | — | — | 1 qtr | First report 0 |
CUSHMAN WAKEFIELD PLC | 37.8M | $839.6M | 8.4% | $22.24 | 0.00% | 1 qtr | First report 0 |
LIFE TIME GROUP HOLDINGS INC | 43.1M | $741.2M | 7.4% | $17.21 | 0.00% | 1 qtr | First report 0 |
PROGYNY INC | 10M | $503.5M | 5.0% | $50.35 | 0.00% | 1 qtr | First report 0 |
CONVEY HEALTH SOLUTIONS HLDG | 54.7M | $457.3M | 4.6% | — | — | 1 qtr | First report 0 |
ELEVANCE HEALTH INC FORMERLY | 923,113 | $427.9M | 4.3% | $432.06 | 0.00% | 1 qtr | First report 0 |
FIDELITY NATL INFORMATION SV | 3.4M | $375.8M | 3.8% | $95.82 | 0.00% | 1 qtr | First report 0 |
THOMSON REUTERS CORP | 2.5M | $300.1M | 3.0% | $108.71 | 0.00% | 1 qtr | First report 0 |
ALLOGENE THERAPEUTICS INC | 18.7M | $279.2M | 2.8% | $14.92 | 0.00% | 1 qtr | First report 0 |
ANAPLAN INC | 5.6M | $257.8M | 2.6% | — | — | 1 qtr | First report 0 |
LIBERTY MEDIA CORP-LIBERTY-C | 3.5M | $222.6M | 2.2% | $56.91 | 0.00% | 1 qtr | First report 0 |
COMCAST CORP NEW | 3.8M | $190.1M | 1.9% | $39.64 | 0.00% | 1 qtr | First report 0 |
TOAST INC | 5.5M | $189.8M | 1.9% | $34.71 | -37.40% | 1 qtr | First report 0 |
PEGASYSTEMS INC | 1.5M | $166.6M | 1.7% | $55.12 | 0.00% | 1 qtr | First report 0 |
MICROSOFT CORP | 466,470 | $156.9M | 1.6% | $323.37 | 0.00% | 1 qtr | First report 0 |
JOHNSON CONTROLS INTERNATION | 1.8M | $149.6M | 1.5% | $74.47 | 0.00% | 1 qtr | First report 0 |
FIDELITY NATL FINL INC | 2.9M | $148.8M | 1.5% | $39.80 | 0.00% | 1 qtr | First report 0 |
Blackbaud Inc | 1.7M | $135.6M | 1.4% | $78.98 | 0.00% | 1 qtr | First report 0 |
OPTIMUM COMMUNICATIONS INC | 8M | $129.8M | 1.3% | $16.61 | 0.00% | 1 qtr | First report 0 |
TPG GP A, LLC manages $10B across 43 positions as of Q4 2021. Top holdings: LFST (16.7%), MCFE (15.4%), CWK (8.4%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
First quarter we have for this fund: 43 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $10.0B across 43 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR